BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Si Y, Chen YB, Chen SJ, Zheng YQ, Liu X, Liu Y, Jiang HL, Xu G, Li ZH, Huang QH, Xiong H, Zhang ZG. TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction. Sci Rep 2015;5:16683. [PMID: 26639190 DOI: 10.1038/srep16683] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Koizumi H, Suzuki H, Kawaguchi R, Hashida K, Hohchi N, Ohkubo J, Tabata T, Kitamura T. Presence of osteoclasts in middle ear cholesteatoma: a study of undecalcified bone sections. Acta Oto-Laryngologica 2017;137:127-30. [DOI: 10.1080/00016489.2016.1222549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Lipschitz N, Earl BR, Cripe TP, Samy RN. Oncolytic virotherapy: a potential therapeutic approach for cholesteatoma. Curr Opin Otolaryngol Head Neck Surg 2020;28:281-5. [PMID: 32833886 DOI: 10.1097/MOO.0000000000000651] [Reference Citation Analysis]
3 Fischer N, Plaikner M, Schartinger VH, Kremser C, Riechelmann H, Schmutzhard J, Gottfried T, Dejaco D, Tauber H, Josip E, Henninger B. MRI of middle ear cholesteatoma: The importance of observer reliance from diffusion sequences. J Neuroimaging 2021. [PMID: 34398501 DOI: 10.1111/jon.12919] [Reference Citation Analysis]
4 Westerberg J, Tideholm E, Piersiala K, Drakskog C, Kumlien Georén S, Mäki-Torkko E, Cardell LO. JAK/STAT Dysregulation With SOCS1 Overexpression in Acquired Cholesteatoma-Adjacent Mucosa. Otol Neurotol 2021;42:e94-e100. [PMID: 33201080 DOI: 10.1097/MAO.0000000000002850] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Fischer N, Schartinger VH, Dejaco D, Schmutzhard J, Riechelmann H, Plaikner M, Henninger B. Readout-Segmented Echo-Planar DWI for the Detection of Cholesteatomas: Correlation with Surgical Validation. AJNR Am J Neuroradiol 2019;40:1055-9. [PMID: 31122917 DOI: 10.3174/ajnr.A6079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
6 Xie S, Wang X, Ren J, Liu W. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma. Eur Arch Otorhinolaryngol 2017;274:2071-8. [DOI: 10.1007/s00405-016-4422-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
7 Yemiş T, Özgür A, Başbulut E, Özdemir D, Akgül G, Mehel DM, Bilgin Acar M, Çelebi M. Bone turnover in chronic otitis media with bone destruction. Eur Arch Otorhinolaryngol 2020;277:2229-33. [DOI: 10.1007/s00405-020-05970-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Elias ML, Jyung RW. Exophytic Cholesteatoma. Ear Nose Throat J 2019;98:317-8. [PMID: 31309864 DOI: 10.1177/0145561318824261] [Reference Citation Analysis]
9 Zhang C, Chen M, Chi Z. Cytokine secretion and pyroptosis of cholesteatoma keratinocytes mediated by AIM2 inflammasomes in response to cytoplasmic DNA. Mol Med Rep 2021;23:344. [PMID: 33760111 DOI: 10.3892/mmr.2021.11983] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Li X. Endoplasmic reticulum stress regulates inflammation in adipocyte of obese rats via toll-like receptors 4 signaling. Iran J Basic Med Sci 2018;21:502-7. [PMID: 29922431 DOI: 10.22038/IJBMS.2018.27346.6674] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Schürmann M, Oppel F, Shao S, Volland-Thurn V, Kaltschmidt C, Kaltschmidt B, Scholtz LU, Sudhoff H. Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism. Cell Commun Signal 2021;19:25. [PMID: 33627146 DOI: 10.1186/s12964-020-00690-y] [Reference Citation Analysis]
12 Gong N, Zhu W, Xu R, Teng Z, Deng C, Zhou H, Xia M, Zhao M. Keratinocytes-derived exosomal miRNA regulates osteoclast differentiation in middle ear cholesteatoma. Biochem Biophys Res Commun 2020;525:341-7. [PMID: 32093888 DOI: 10.1016/j.bbrc.2020.02.058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Drakskog C, de Klerk N, Westerberg J, Mäki-Torkko E, Georén SK, Cardell LO. Extensive qPCR analysis reveals altered gene expression in middle ear mucosa from cholesteatoma patients. PLoS One 2020;15:e0239161. [PMID: 32915926 DOI: 10.1371/journal.pone.0239161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhang C, Liu YW, Chi Z, Chen B. Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes. PPAR Res 2020;2020:8864813. [PMID: 33424958 DOI: 10.1155/2020/8864813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kılıçkaya MM, Aynali G, Tuz M, Bagcı Ö. Is There A Systemıc Inflammatory Effect of Cholesteatoma? Int Arch Otorhinolaryngol 2017;21:42-5. [PMID: 28050207 DOI: 10.1055/s-0036-1584363] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Imai R, Sato T, Iwamoto Y, Hanada Y, Terao M, Ohta Y, Osaki Y, Imai T, Morihana T, Okazaki S, Oshima K, Okuzaki D, Katayama I, Inohara H. Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling. J Assoc Res Otolaryngol 2019;20:449-59. [PMID: 31254133 DOI: 10.1007/s10162-019-00727-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
17 Schürmann M, Greiner JFW, Volland-Thurn V, Oppel F, Kaltschmidt C, Sudhoff H, Kaltschmidt B. Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS. Cells 2020;9:E199. [PMID: 31947538 DOI: 10.3390/cells9010199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]